Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

873 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution model.
Kunimasa K, Hirotsu Y, Nakamura H, Tamiya M, Iijima Y, Ishida H, Hamamoto Y, Maniwa T, Kimura T, Nishino K, Goto T, Amemiya K, Mochizuki H, Oyama T, Nakatsuka SI, Kumagai T, Okami J, Higashiyama M, Imamura F, Omata M. Kunimasa K, et al. Among authors: nishino k. Cancer Genet. 2020 Feb;241:51-56. doi: 10.1016/j.cancergen.2019.12.006. Epub 2019 Dec 25. Cancer Genet. 2020. PMID: 31917104
Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer.
Kunimasa K, Hirotsu Y, Amemiya K, Nagakubo Y, Goto T, Miyashita Y, Kakizaki Y, Tsutsui T, Otake S, Kobayashi H, Higuchi R, Inomata K, Kumagai T, Mochizuki H, Nakamura H, Nakatsuka SI, Nishino K, Imamura F, Kumagai T, Oyama T, Omata M. Kunimasa K, et al. Among authors: nishino k. Cancer Med. 2020 Jul;9(13):4501-4511. doi: 10.1002/cam4.3089. Epub 2020 Apr 29. Cancer Med. 2020. PMID: 32351019 Free PMC article.
Multiregional sequence revealed SMARCA4 R1192C mutant clones acquired EGFR C797S mutation in the metastatic site of an EGFR-mutated NSCLC patient.
Kunimasa K, Hirotsu Y, Miyashita Y, Goto T, Amemiya K, Mochizuki H, Samamoto I, Ohki T, Oyama T, Honma K, Imamura F, Nishino K, Kumagai T, Omata M. Kunimasa K, et al. Among authors: nishino k. Lung Cancer. 2020 Oct;148:28-32. doi: 10.1016/j.lungcan.2020.07.035. Epub 2020 Aug 3. Lung Cancer. 2020. PMID: 32777674
Late recurrence of lung adenocarcinoma harboring EGFR exon 20 insertion (A763_Y764insFQEA) mutation successfully treated with osimertinib.
Kunimasa K, Nishino K, Kukita Y, Matsumoto S, Kawachi H, Kawamura T, Inoue T, Tamiya M, Honma K, Sugimoto N, Yamasaki T, Imamura F, Goto K, Kumagai T. Kunimasa K, et al. Among authors: nishino k. Cancer Genet. 2021 Aug;256-257:57-61. doi: 10.1016/j.cancergen.2021.04.001. Epub 2021 Apr 10. Cancer Genet. 2021. PMID: 33901930
EML4-ALK fusion variant.3 and co-occurrent PIK3CA E542K mutation exhibiting primary resistance to three generations of ALK inhibitors.
Kunimasa K, Hirotsu Y, Kukita Y, Ueda Y, Sato Y, Kimura M, Otsuka T, Hamamoto Y, Tamiya M, Inoue T, Kawamura T, Nishino K, Amemiya K, Goto T, Mochizuki H, Honma K, Omata M, Kumagai T. Kunimasa K, et al. Among authors: nishino k. Cancer Genet. 2021 Aug;256-257:131-135. doi: 10.1016/j.cancergen.2021.05.010. Epub 2021 May 28. Cancer Genet. 2021. PMID: 34130229
873 results